Xcellance Medical Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 5.00 M
as on 16-06-2024
- Company Age 16 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.44 Cr
as on 16-06-2024
- Revenue 48.33%
(FY 2023)
- Profit 101.60%
(FY 2023)
- Ebitda 93.10%
(FY 2023)
- Net Worth 55.81%
(FY 2023)
- Total Assets 44.08%
(FY 2023)
About Xcellance Medical Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹4.44 Cr.
Snehal Narkhede and Pradip Narkhede serve as directors at the Company.
- CIN/LLPIN
U33119MH2008PTC177419
- Company No.
177419
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Jan 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Xcellance Medical Technologies Private Limited offer?
Xcellance Medical Technologies Private Limited offers a wide range of products and services, including Forceps & Graspers, Insufflators, Endoscopy & Laparoscopy instruments, Surgical Equipments, Strapping & Sealing Machines, Seal Machines, Surgical & ICU Equipments, OT Tables, Operation Theater Equipments, Endoscopy Instruments.
Who are the key members and board of directors at Xcellance Medical Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Snehal Narkhede  | Director | 07-Jan-2008 | Current |
| Pradip Narkhede | Director | 07-Jan-2008 | Current |
Financial Performance of Xcellance Medical Technologies.
Xcellance Medical Technologies Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 48.33% increase. The company also saw a substantial improvement in profitability, with a 101.6% increase in profit. The company's net worth Soared by an impressive increase of 55.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xcellance Medical Technologies?
In 2022, Xcellance Medical Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Feb 2016 | ₹4.44 Cr | Open |
How Many Employees Work at Xcellance Medical Technologies?
Xcellance Medical Technologies has a workforce of 299 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xcellance Medical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xcellance Medical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
